Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases
- Conditions
- Supportive Care Needs of Caregivers
- Interventions
- Behavioral: online surveys
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 170
- Registration Number
- NCT03990428
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies
- Conditions
- EBV LymphomasEBV-associated Malignancies
- Interventions
- Biological: EBV-specific T-cells
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT03988582
Exercise Treatment With Standard Therapy for Metastatic Breast Cancer
- Conditions
- Hormone Receptor Positive Metastatic Breast Cancer
- Interventions
- Other: Exercise Treatment
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 54
- Registration Number
- NCT03988595
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity), Commack, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: Left Ventricular Ejection Fraction
- First Posted Date
- 2019-06-12
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 190
- Registration Number
- NCT03983382
- Locations
- 🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only), Hartford, Connecticut, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ BaskingRidge (Consent and follow-up only), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Consent and Follow up), Middletown, New Jersey, United States
Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
- Conditions
- Debulking Surgery for Ovarian Cancer
- Interventions
- Dietary Supplement: Ensure Surgery Immunonutrition Shake supplementsOther: Daily Food Intake form
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT03956095
- Locations
- 🇺🇸
Baptist Alliance MCI, Miami, Florida, United States
🇺🇸Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease
- Conditions
- Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
- Interventions
- Other: Topical vehicle/moisturizer cream
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT03954236
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
- Conditions
- Neuroblastoma Survivors
- Interventions
- Other: Urine sample
- First Posted Date
- 2019-05-13
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT03947346
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
- Conditions
- Mantle Cell LymphomaDiffuse Large B-cell Lymphoma
- Interventions
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT03939182
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis
- Conditions
- Breast Screening
- Interventions
- Diagnostic Test: Contrast-Enhanced Spectral Mammography
- First Posted Date
- 2019-04-29
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT03929822
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma
- First Posted Date
- 2019-04-22
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT03922880
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States